OCTALFA
Octalfa is a France-based venture capital firm that offers a range of financial services.
OCTALFA
Social Links:
Industry:
Finance
Founded:
2007-01-01
Status:
Active
Contact:
+33 (0)4 37 49 87 20
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Apache Microsoft Exchange Online OVH Microsoft DNS
Similar Organizations
Mouro Capital
Mouro Capital is a venture capital firm backing entrepreneurs who are shaping the future of financial services.
Redrock Capital
Redrock Capital is a venture capital firm that offers and provides banking and other financial services.
Current Employees Featured
Annie Beucler
Annie Beucler Administrative Manager @ Octalfa Administrative Manager
Laurence Simon
Laurence Simon Administrative and Financial Director @ Octalfa Administrative and Financial Director 2016-11-03
Jérémy Bastid
Jérémy Bastid R&D Director @ Octalfa R&D Director 2016-10-01
Julien Alberici
Julien Alberici Operations Manager @ Octalfa Operations Manager
Gilles Alberici
Gilles Alberici President @ Octalfa President
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-12-01 | ORPHELIA Pharma | Octalfa investment in Venture Round - ORPHELIA Pharma | N/A |
2016-10-17 | Mathym | Octalfa investment in Venture Round - Mathym | 2.2 M EUR |
2015-10-09 | ORPHELIA Pharma | Octalfa investment in Venture Round - ORPHELIA Pharma | N/A |
2015-03-17 | Amolyt Pharma | Octalfa investment in Venture Round - Amolyt Pharma | 1.8 M EUR |
2014-09-10 | NightSwapping | Octalfa investment in Seed Round - NightSwapping | 2 M EUR |
2014-06-30 | Mathym | Octalfa investment in Seed Round - Mathym | 600 K EUR |
2012-10-09 | e(ye)BRAIN | Octalfa investment in Series B - e(ye)BRAIN | 3.3 M USD |
2012-06-04 | Amolyt Pharma | Octalfa investment in Venture Round - Amolyt Pharma | 3.3 M EUR |
2011-05-10 | Laboratories JUVISE Pharmaceuticals | Octalfa investment in Venture Round - Laboratories JUVISE Pharmaceuticals | 2.1 M EUR |
2011-04-26 | Graftys | Octalfa investment in Venture Round - Graftys | 4 M EUR |